Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis

N. Lanzarone (Siena, Italy), V. Alonzi (Siena, Italy), L. Bergantini (Siena, Italy), F. Bianchi (Siena, Italy), M. D'Alessandro (Siena, Italy), P. Rottoli (Siena, Italy), R. Refini (Siena, Italy), M. Pieroni (Siena, Italy), E. Bargagli (Siena, Italy), M. Mazzei (Siena, Italy), F. Gentili (Siena, Italy), P. Sestini (Siena, Italy)

Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Session: Immune-mediated interstitial lung diseases: from bench to bedside
Session type: Thematic Poster
Number: 1359
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Lanzarone (Siena, Italy), V. Alonzi (Siena, Italy), L. Bergantini (Siena, Italy), F. Bianchi (Siena, Italy), M. D'Alessandro (Siena, Italy), P. Rottoli (Siena, Italy), R. Refini (Siena, Italy), M. Pieroni (Siena, Italy), E. Bargagli (Siena, Italy), M. Mazzei (Siena, Italy), F. Gentili (Siena, Italy), P. Sestini (Siena, Italy). Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis. 1359

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced sputum and BAL from patients with hypersensitivity pneumonitis
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001

YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis.
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019

Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018

Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Elevated levels of BALF galectin-9 in patients with interstitial pneumonia
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

Serum markers of acute sarcoidosis.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Serum and BALF levels of YKL-40 in patients with alveolar proteinosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Serum TNFα and IL8 as markers of systemic inflammation in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011

Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Levels of TNF-a in blood serum and BALF from children with bronchiolitis obliterans depending on severity of disease
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005

Serum and bronchoalveolar lavage fluid acute phase reactants and cytokine levels in unilateral community acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002

Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis
Source: Eur Respir J , 49 (2) 1501924; DOI: 10.1183/13993003.01924-2015
Year: 2017



Inflammatory cytokine levels in serum and bronchoalveolar lavage fluid and gene polymorphism in young adult patients with bronchiectasis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001